NasoVAX (intranasal flu vaccine) / Altimmune  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NasoVAX (intranasal flu vaccine) / Altimmune
NCT03760549: Study of the Safety and Immunogenicity of NasoVAX Extension

Completed
N/A
8
US
Subjects were administered NasoVAX high dose
Altimmune, Inc.
Influenza
02/19
02/19

Download Options